Clinical laboratory parameters and comorbidities associated with severity of coronavirus disease 2019 (COVID-19) in Kurdistan Region of Iraq
Background: The pandemic coronavirus disease (COVID-19) dramatically spread worldwide. Considering several laboratory parameters and comorbidities may facilitate the assessment of disease severity. Early recognition of disease progression associated with severe cases of COVID-19 is essential for tim...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-08-01
|
| Series: | Practical Laboratory Medicine |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352551722000336 |
| _version_ | 1828518262300737536 |
|---|---|
| author | Hussein Noori Ali Kameran Mohammed Ali Hassan Muhammad Rostam Ayad M. Ali Hassan Mohammad Tawfeeq Mohammed Hassan Fatah Grazziela P. Figueredo |
| author_facet | Hussein Noori Ali Kameran Mohammed Ali Hassan Muhammad Rostam Ayad M. Ali Hassan Mohammad Tawfeeq Mohammed Hassan Fatah Grazziela P. Figueredo |
| author_sort | Hussein Noori Ali |
| collection | DOAJ |
| description | Background: The pandemic coronavirus disease (COVID-19) dramatically spread worldwide. Considering several laboratory parameters and comorbidities may facilitate the assessment of disease severity. Early recognition of disease progression associated with severe cases of COVID-19 is essential for timely patient triaging. Our study investigated the characteristics and role of laboratory results and comorbidities in the progression and severity of COVID-19 cases. Methods: The study was conducted from early-June to mid-August 2020. Blood samples and clinical data were taken from 322 patients diagnosed with COVID-19 at Qala Hospital, Kalar, Kurdistan Region of Iraq. Biological markers used in this study include complete blood count (CBC), D-dimer, erythrocyte sedimentation rate (ESR), serum ferritin, blood sugar, C-reactive protein (CRP) and SpO2. Results: The sample included 154 males (47.8%) and 168 females (52.2%). Most females were in the mild and moderate symptom groups, while males developed more severe symptoms. Regarding comorbidities, diabetes mellitus was considered the greatest risk factor for increasing the severity of COVID-19 symptoms. As for biological parameters, WBC, granulocytes, ESR, Ferritin, CRP and D-Dimer were elevated significantly corresponding to the severity of the disease, while lymphocytes and SpO2 showed the opposite pattern. Higher RBC was significantly associated with COVID-19 severity, especially in females. Conclusion: Gender, age and diabetes mellitus are important prognostic risk factors associated with severity and mortality of COVID-19. Relative to non-severe COVID-19, severe cases are characterized by an increase of most biological markers. These markers could be used to recognize severe cases and to monitor the clinical course of COVID-19. |
| first_indexed | 2024-12-11T18:52:53Z |
| format | Article |
| id | doaj.art-05fad018643c4861af3b8814532185df |
| institution | Directory Open Access Journal |
| issn | 2352-5517 |
| language | English |
| last_indexed | 2024-12-11T18:52:53Z |
| publishDate | 2022-08-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Practical Laboratory Medicine |
| spelling | doaj.art-05fad018643c4861af3b8814532185df2022-12-22T00:54:14ZengElsevierPractical Laboratory Medicine2352-55172022-08-0131e00294Clinical laboratory parameters and comorbidities associated with severity of coronavirus disease 2019 (COVID-19) in Kurdistan Region of IraqHussein Noori Ali0Kameran Mohammed Ali1Hassan Muhammad Rostam2Ayad M. Ali3Hassan Mohammad Tawfeeq4Mohammed Hassan Fatah5Grazziela P. Figueredo6College of Medicine, University of Garmian, Kalar, Kurdistan region, IraqMedical Lab Technology Department, Kalar Technical College, Sulaimani Polytechnic University, Kalar, Kurdistan Region, IraqCollege of Medicine, University of Garmian, Kalar, Kurdistan region, Iraq; Mmunology & Immuno-Bioengineering Group, School of Life Sciences, Faculty of Medicine & Health Sciences, University of Nottingham, Nottingham, UK; Corresponding author. College of Medicine, University of Garmian, Kalar, Kurdistan region, Iraq.Department of Chemistry, College of Sciences, University of Garmian, Kalar, Kurdistan region, IraqMedical Lab Technology Department, Kalar Technical College, Sulaimani Polytechnic University, Kalar, Kurdistan Region, IraqMedical Lab Technology Department, Kalar Technical College, Sulaimani Polytechnic University, Kalar, Kurdistan Region, IraqSchool of Computer Science, University of Nottingham, Nottingham, NG8 1BB, UKBackground: The pandemic coronavirus disease (COVID-19) dramatically spread worldwide. Considering several laboratory parameters and comorbidities may facilitate the assessment of disease severity. Early recognition of disease progression associated with severe cases of COVID-19 is essential for timely patient triaging. Our study investigated the characteristics and role of laboratory results and comorbidities in the progression and severity of COVID-19 cases. Methods: The study was conducted from early-June to mid-August 2020. Blood samples and clinical data were taken from 322 patients diagnosed with COVID-19 at Qala Hospital, Kalar, Kurdistan Region of Iraq. Biological markers used in this study include complete blood count (CBC), D-dimer, erythrocyte sedimentation rate (ESR), serum ferritin, blood sugar, C-reactive protein (CRP) and SpO2. Results: The sample included 154 males (47.8%) and 168 females (52.2%). Most females were in the mild and moderate symptom groups, while males developed more severe symptoms. Regarding comorbidities, diabetes mellitus was considered the greatest risk factor for increasing the severity of COVID-19 symptoms. As for biological parameters, WBC, granulocytes, ESR, Ferritin, CRP and D-Dimer were elevated significantly corresponding to the severity of the disease, while lymphocytes and SpO2 showed the opposite pattern. Higher RBC was significantly associated with COVID-19 severity, especially in females. Conclusion: Gender, age and diabetes mellitus are important prognostic risk factors associated with severity and mortality of COVID-19. Relative to non-severe COVID-19, severe cases are characterized by an increase of most biological markers. These markers could be used to recognize severe cases and to monitor the clinical course of COVID-19.http://www.sciencedirect.com/science/article/pii/S2352551722000336SARS-CoV-2COVID-19 severityLaboratory parametersComorbidities |
| spellingShingle | Hussein Noori Ali Kameran Mohammed Ali Hassan Muhammad Rostam Ayad M. Ali Hassan Mohammad Tawfeeq Mohammed Hassan Fatah Grazziela P. Figueredo Clinical laboratory parameters and comorbidities associated with severity of coronavirus disease 2019 (COVID-19) in Kurdistan Region of Iraq Practical Laboratory Medicine SARS-CoV-2 COVID-19 severity Laboratory parameters Comorbidities |
| title | Clinical laboratory parameters and comorbidities associated with severity of coronavirus disease 2019 (COVID-19) in Kurdistan Region of Iraq |
| title_full | Clinical laboratory parameters and comorbidities associated with severity of coronavirus disease 2019 (COVID-19) in Kurdistan Region of Iraq |
| title_fullStr | Clinical laboratory parameters and comorbidities associated with severity of coronavirus disease 2019 (COVID-19) in Kurdistan Region of Iraq |
| title_full_unstemmed | Clinical laboratory parameters and comorbidities associated with severity of coronavirus disease 2019 (COVID-19) in Kurdistan Region of Iraq |
| title_short | Clinical laboratory parameters and comorbidities associated with severity of coronavirus disease 2019 (COVID-19) in Kurdistan Region of Iraq |
| title_sort | clinical laboratory parameters and comorbidities associated with severity of coronavirus disease 2019 covid 19 in kurdistan region of iraq |
| topic | SARS-CoV-2 COVID-19 severity Laboratory parameters Comorbidities |
| url | http://www.sciencedirect.com/science/article/pii/S2352551722000336 |
| work_keys_str_mv | AT husseinnooriali clinicallaboratoryparametersandcomorbiditiesassociatedwithseverityofcoronavirusdisease2019covid19inkurdistanregionofiraq AT kameranmohammedali clinicallaboratoryparametersandcomorbiditiesassociatedwithseverityofcoronavirusdisease2019covid19inkurdistanregionofiraq AT hassanmuhammadrostam clinicallaboratoryparametersandcomorbiditiesassociatedwithseverityofcoronavirusdisease2019covid19inkurdistanregionofiraq AT ayadmali clinicallaboratoryparametersandcomorbiditiesassociatedwithseverityofcoronavirusdisease2019covid19inkurdistanregionofiraq AT hassanmohammadtawfeeq clinicallaboratoryparametersandcomorbiditiesassociatedwithseverityofcoronavirusdisease2019covid19inkurdistanregionofiraq AT mohammedhassanfatah clinicallaboratoryparametersandcomorbiditiesassociatedwithseverityofcoronavirusdisease2019covid19inkurdistanregionofiraq AT grazzielapfigueredo clinicallaboratoryparametersandcomorbiditiesassociatedwithseverityofcoronavirusdisease2019covid19inkurdistanregionofiraq |